ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2021 and Provide a Corporate Strategic Update

Rhea-AI Summary

ThermoGenesis Holdings, Inc. (Nasdaq: THMO) will announce its third-quarter financial results for the period ending September 30, 2021, along with a corporate strategic update on November 12, 2021, after market close. A conference call will follow at 1:30 PM PT / 4:30 PM ET. Interested parties can participate by dialing the provided numbers or accessing the live webcast through the company’s investor relations page. A replay of the webcast will be available for three months. ThermoGenesis is focused on automated technologies for CAR-T and cell-based therapies.

Positive

• Upcoming financial results announcement expected to provide insights into company performance.
• Strategic update may indicate positive developments in automated technologies for CAR-T therapies.

Negative

• None.

RANCHO CORDOVA, Calif., Nov. 5, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the third quarter ended September 30, 2021 and provide a corporate strategic update on Friday, November 12, 2021, after the close of trading. A conference call and webcast will follow at 1:30 p.m. PT/ 4:30 p.m. ET.

To participate in the conference call, please dial 1-844-889-4331 (domestic), 1-412-380-7406 (international) or 1-866-605-3852 (Canada). To access a live webcast of the call, please visit: https://thermogenesis.com/investors/news-and-events/events-webcasts.

A webcast replay will be available on ThermoGenesis' website for three months by visiting the Investor page of the Company's website at www.thermogenesis.com.

About ThermoGenesis Holdings, Inc.
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress™ platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. For more information about ThermoGenesis, please visit: www.thermogenesis.com.

Company Contact:
Wendy Samford
916-858-5191
ir@ThermoGenesis.com

Investor Contact:
Paula Schwartz, Rx Communications
917-322-2216
pschwartz@rxir.com

 

View original content:https://www.prnewswire.com/news-releases/thermogenesis-holdings-to-announce-financial-results-for-the-third-quarter-ended-september-30-2021-and-provide-a-corporate-strategic-update-301417433.html

SOURCE ThermoGenesis Holdings, Inc.

FAQ

When will ThermoGenesis Holdings announce its Q3 financial results?

ThermoGenesis Holdings will announce its Q3 financial results on November 12, 2021, after market close.

What is the ticker symbol for ThermoGenesis Holdings?

The ticker symbol for ThermoGenesis Holdings is THMO.

How can I listen to the ThermoGenesis earnings call?

You can listen to the ThermoGenesis earnings call by dialing the provided phone numbers or by accessing the live webcast on their investor relations page.

What time is the ThermoGenesis conference call scheduled?

The ThermoGenesis conference call is scheduled for 1:30 PM PT / 4:30 PM ET on November 12, 2021.